Skip to main content
SpringerLink
Log in

The hereditary hemochromatosis gene (HFE)

A MHC Class I-Like Gene That Functions in the Regulation of Iron Homeostasis

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

The iron overload disorder, hereditary hemochromatosis, is one of the most common genetic diseases of individuals of Northern European descent. The disorder is characterized by the progressive accumulation of dietary iron in the major organs of the body, which if not diagnosed, leads to numerous medical maladies and eventually death. The locus for this disorder was mapped by genetic linkage to the short arm of chromosome over twenty years ago, but it was not until 1996 that the gene for this disorder was cloned by an identity-by-descent positional cloning approach. The gene, called HFE, encodes a major histocompatibility complex (MHC) class I like protein that is mutated in approx 85% of all individuals known to have hereditary hemochromatosis (HH). Since the cloning of the HFE gene, considerable work has been carried out which has furthered our understanding of the genetics of this prevalent disorder. In addition, with the identification of the transferrin receptor as a protein capable of interacting with HFE we are now beginning to understand how a protein with the structural characteristics of an MHC class I molecule can influence cellular iron homeostasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dadone MM, Kushner JP, Edwards CQ, Bishop DT, Skolnick MH: Hereditary Hemochromatosis analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol 1982;78:196–207.

    PubMed  CAS  Google Scholar 

  2. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP: Prevalence of hemochromatosis among 11,065 presumably healthy donors. N Engl J Med 1988;318:1355–1362,.

    Article  PubMed  CAS  Google Scholar 

  3. McLaren CE, Gordeuk VR, Looker AC, Hasselblad V, Edward CQ, Griffen LM, Kushner JP, Brittenham GM: Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood 1995;86:2021–2027.

    PubMed  CAS  Google Scholar 

  4. Bothwell TH, Charlton RW, Motulsky AG: Hemochromatosis, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The metabolic and molecular basis of inherited disease. New York, McGraw-Hill, 1995, pp. 2237–2269.

    Google Scholar 

  5. Bacon BR. Tavill AS: Hemochromatosis and the iron overload syndromes, in Zakim D, Boyer TD (eds): Hepatology. A textbook of liver disease. Philadelphia, W.B. Saunders, 1996, pp. 1439–1472.

    Google Scholar 

  6. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, etal.: A novel MHC class 1 -like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics 1996;13:399–408.

    Article  PubMed  CAS  Google Scholar 

  7. Simon M, Bourel M, Fauchet R, Genetet B: Association of HLAA3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 1976;17:332–334.

    Article  PubMed  CAS  Google Scholar 

  8. Jazwinska EC, Lee SC, Webb SI, Halliday JW, Powell LW: Localization of the hemochromatosis gene close to D6S105. Am J Hum Genet 1993;53:347–352.

    PubMed  CAS  Google Scholar 

  9. Lauer P, Schneider SS, Gnirke A: Construction and validation of yeast artifical chromosome contig maps by RecA-assisted restriction endonuclease cleavage. Proc Natl Acad Sci USA 1998;95:11318–11323.

    Article  PubMed  CAS  Google Scholar 

  10. Thomas W, Fullan A, Loeb DB, McClelland EE, Bacon BR, Wolff RK: A haplotype and linkage disequilibrium analysis of the hemochromatosis gene region. Hum Genet 1998;102:517–525.

    Article  PubMed  CAS  Google Scholar 

  11. Lauer P, Meyer NC, Prass CE, Stranes SS, Wolff RK, Gnirke A: Clone-Contig and STS maps of the hereditary hemochromatosis region on human chromosome 6p21.3-p22. Genome Research 1997;7:457–470.

    PubMed  CAS  Google Scholar 

  12. Sesse NK, Venditti CP, Chorney KA, Gerhard GS, Ma J, Hudson TJ, Phatak P, Chorney MJ: Localization of the hemochromatosis disease gene: Linkage disequlibrium analysis using an american patient collection. Boold Cells, Molecules, and Diseases 1996;22:36–46.

    Article  Google Scholar 

  13. Ruddy DA, Kronmal GS, Lee VK, Mintier GA, Quintana L, Domingo RJ, et al.: A. 1.1-Mb transcript map of the hereditary hemochromatosis locus. Genome Research 1997;7:441–456.

    PubMed  CAS  Google Scholar 

  14. De Sousa M, Reimao R, Lacerda R, Hugo P, Kaufmann SHE, Porto G: Iron overload in β2-microglobulindeficient mice. Immunol. Lett. 1994 ;39:105–111.

    Article  PubMed  Google Scholar 

  15. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP, Walsh TP: Haemochromatosis and HLA-H. Nature Genetics 1996;14:250–251.

    Article  Google Scholar 

  16. Jouanolle AM, Gandon G, Jezequel, P. M. B, Campion ML, Yaouanq J, Mosser J, Fergelot P, Chauvel B, Bouric P, Cam G, Andrieux N, Gicquel I, Le Gall J, David V: Haemochromatosis and HLA-H. Nature Genetics 1996;14:251–252.

    Article  PubMed  CAS  Google Scholar 

  17. Merry Weather-Clarke AT, Pointon JJ, Shearman D, Robson KJH: Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 1997;34:275–278.

    Article  CAS  Google Scholar 

  18. Borot N, Roth M, Malfory L, Demangel C, Vinel J, Pascal J, Coppin H: Mutations in the MHC class I-like candidate gene of hemochromatosis in French patients. Immunogenetics 1997;45: 320–324.

    Article  PubMed  CAS  Google Scholar 

  19. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, Pockros P, Kosty M, Venditti CP, Phatak PD, Seese NK, Chorney KA, Elshof AET, Gerhard GS, Chorney M: Mutation analysis in hereditary hemochromatosis. Blood Cells, Molecules, and Diseases 1996;31:187–194.

    Article  Google Scholar 

  20. Carella M, D’Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, Girelli D, Roetto A, Franco B, Gasparini P, Camaschella C: Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am. J. Hum. Genet. 1997;60:828–832.

    PubMed  CAS  Google Scholar 

  21. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987;329:506–512.

    Article  PubMed  CAS  Google Scholar 

  22. Beutler E: The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997;61:762–764.

    Article  PubMed  CAS  Google Scholar 

  23. Risch N: Haemochromatosis, Hfe and genetic complexity. Nat Genet 1997;17:375–376.

    Article  PubMed  CAS  Google Scholar 

  24. Chang J-G, Liu T-C, Lin S-F: Rapid diagnosis of the HLA-H gene Cys282Tyr mutation in hemochromatosis by polymerase chain reaction-a very rare mutation in the Chinese population. Blood 1997;89:3492–3493.

    PubMed  CAS  Google Scholar 

  25. Cullen LM, Gao X, Easteal S, Jazwinska EC: The hemochromatosis 845 G to A and 187 C to G mutations: Prevalence in noncaucasian populations. Am J Hum Genet 1998;62:1403–1407.

    Article  PubMed  CAS  Google Scholar 

  26. Beutler E, West C, Gelbart T: HLA-H and associated proteins in patients with hemochromatosis. Mol Med 1997;3:397–402.

    PubMed  CAS  Google Scholar 

  27. Tsuchihashi Z, Hansen SL, Quintana L, Kronmal GS, Mapa FA, Feder JN, Wolff RK: Transferrin receptor mutation analysis in hereditary hemochromatosis patients. Blood Cells, Molecules, and Diseases 1998;31:317–321.

    Article  Google Scholar 

  28. Malissen M, Malissen B, Jordan BR: Exon/intron organization and complete nucleotide sequence of an HLA gene. Proc Natl Acad Sci USA 1982;79:893–897.

    Article  PubMed  CAS  Google Scholar 

  29. Ting JP, Baldwin AS: Regulaton of MHC gene expression. Current Opinion in Immunology 1993; 5:8–16.

    Article  PubMed  CAS  Google Scholar 

  30. Feder JN, Penny DM, Irrinki A, Mintier GA, Lebron JA, Gross CN, Lee L, Tsuchihashi Z, Enns CA, Bjorkman PJ, Schatzman RC: The hereditary hemochromatosis gene and iron homeostasis: Molecular Biology of Hematopoiesis 1999;6.

  31. Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R: β2Microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 1990;344:742–746.

    Article  PubMed  CAS  Google Scholar 

  32. Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC: The hemochromatosis founder mutation in HLA-H disrupts b2-microglobulin interaction and cell surface expression. J Biol Chem 1997;272:14025–14028.

    Article  PubMed  CAS  Google Scholar 

  33. Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, Schatzman RC, Britton RS, Bacon BR, Sly WS: Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with b2-microglobulin,intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 1997;94:12384–12389.

    Article  PubMed  CAS  Google Scholar 

  34. Parkkila S, Waheed A, Britton RS, Feder JN, Tsuchihashi Z, Schatzman RC, Bacon BR, Sly WS: Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA 1997; 94:2534–2539.

    Article  PubMed  CAS  Google Scholar 

  35. Feder JN, Penny DM, Irrinke A, Lee VK, Lebron JA, Waston N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC: The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1988;95:1472–1477.

    Article  Google Scholar 

  36. Parkkila S, Waheed A, Britton RS, R.B.B, Zhou XY, Tomatsu S, Fleming RE, Sly WS: Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997;94:13198–13202.

    Article  PubMed  CAS  Google Scholar 

  37. Gross CN, Irrinki A, Feder JN, Enns CA: Co-trafficking of HFE with transferrin receptor implies role in intracellular iron regulation. J Biol Chem 1998;273:22068–22074.

    Article  PubMed  CAS  Google Scholar 

  38. Penhallow RC, Brown-Mason A, Woodworth RC: Comparative studies of the binding and growthsupportive ability of mammalian transferrins in human cells. 1986;J Cell Physiol 1986;128:251–260.

    Article  PubMed  CAS  Google Scholar 

  39. Lebron JA, Bennett MJ, Chirino AJ, Snow PM, Minder GA, Feder JN, Bjorkman PJ: Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998;93:111–123.

    Article  PubMed  CAS  Google Scholar 

  40. Madden DR, Gorga JC, Strominger JL, Wiley DC: The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992;70:1035–1048.

    Article  PubMed  CAS  Google Scholar 

  41. Hashimoto K, Hirai M, Kurosawa Y: Identification of a mouse homolog for the human haemochromatosis candidate gene. Biochemcal and Biophyiscal Research Communications 1997;230:35–39.

    Article  CAS  Google Scholar 

  42. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jinxing J, Fei Y, Brunt EM, Ruddy DA, Prass CE, Schatzman RC, O’Neill R, Britton RS, Bacon BR, Sly WS: HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998;95:2492–2497.

    Article  PubMed  CAS  Google Scholar 

  43. McLaren GD, Nathanson MH, Jacobs A, Trevett D, Thomson W: Regulation of intestinal iron absroption and mucosal iron kinetics in hereditary hemochromatosis. 1991;J Lab Clin Med 117:390–401.

    PubMed  CAS  Google Scholar 

  44. Gunshin H, Mackenzie B, Bergor UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Matthias AH: Cloning and characterization of a mammalian proton-coupled metal-iron transporter. 1997;388:482–488.

    CAS  Google Scholar 

  45. Fleming MD, Trenor CC, Su MA, Foernzler D, Beier DR, Dietrich WF, Andrews NC: Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transport gene. Nat Genet 1997; 16:383–386.

    PubMed  CAS  Google Scholar 

  46. Banerjee DB, Flanagan PR, Cluett J, Valberg LS: Transferrin receptors in the human gastrointestinal tract. Gastroenterology 1986;91:861–869.

    PubMed  CAS  Google Scholar 

  47. Huebers HA, Huebers E, Csiba E, Rummel W, Finch CA: The significance of transferrin for intestinal iron absorption. Blood 1983; 61:283–290.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bristol-Myers Squibb, Pharmaceutical Research Institute, 08543-5400, Princeton, NJ

    John N. Feder

Authors
  1. John N. Feder
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feder, J.N. The hereditary hemochromatosis gene (HFE). Immunol Res 20, 175–185 (1999). https://doi.org/10.1007/BF02786472

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02786472

Key words

Search

Navigation